This bill prevents health care entities and credentialing boards from discriminating or retaliating against health care providers for ordering innovative therapies or novel therapies [...] The protections provided under the bill do not apply to a health care provider who orders any drug, device, or biological product that is intended to delay or suppress pubertal development in a minor for the purpose of assisting the minor with a gender transition.